Ortin Laboratories Limited (ORTINLAB)
ISIN: INE749B01020 Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
21.1
-0.15(-0.71%)

Ortin Laboratories Limited manufactures and trades in pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders. It provides formulations, such as anti diabetics, anti allergics, sedatives and tranquilisers, anti helmenthetics, analgesics and antipyretics, anti biotics-quinolones, anti biotic-pencillins, antifungal, cephalosporins, and macrolides; and anti anginal and cardio vascular, and antifungal products. The company's formulations also include chemo therapeutics, antacids and anti ulcerants, anti spasmodics, calcium preparations, iron preparations, anti arthritic drugs, protein supplements, enzymes, and vitamins, as well as psychiatry, appetizer, gynaec, and anti retroviral products. In addition, it provides active pharmaceutical ingredient (API) intermediates comprising anti retro viral, anti diabetics, analgesics and antipyretics, anti biotic, antifungal, antacids and anti ulcerants, and anti malarials; and manufactures fine chemicals, and grignard and alkali metal products. Further, the company offers services in the areas of process development, process characterization, analytical research and development, assay development, and product characterization; and diagnostic services, including development of rapid flow kits, assays, and reagents. Additionally, it undertakes long-term contracts for manufacturing intermediates and developing new APIs; and operates as a merchant exporter of pharmaceutical finished formulations. Ortin Laboratories Limited was incorporated in 1986 and is headquartered in Hyderabad, India.

Pricing Updates

TODAY'S HIGH

21.45

TODAY'S LOW

21

52 WEEK HIGH

39.85

52 WEEK LOW

19.3

Major Holders

% of Shares Held by
All Insider

27.71%

% of Shares Held by
Institutions

0.00%

% of Float Held by
Institutions

0.00%

Number of Institutions
Holding Shares

0

Company Overview

MARKET CAP

17.15 Cr.

ETERPRISE VALUE

22.75 Cr.

NO. OF SHARES

81.31 Lakhs

BOOK VALUE

13.536

DIV. YIELD

None%

DEBT

6.14 Cr.

GROSS PROFIT

3.77 Cr.

CASH

59.51 Lakhs

REVENUE

8.42 Cr.

REVENUE/SHARE

10.355

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Investments06.95 Lakhs-7.74 Lakhs-12.77 Lakhs
Change To Liabilities-55.10 Lakhs-58.66 Cr.12.40 Cr.31.01 Cr.
Total cashflows from Investing Activities-12.53 Lakhs6.95 Lakhs-3.09 Cr.-3.26 Cr.
Net Borrowings28.75 Lakhs-2.06 Cr.1.87 Cr.32.92 Lakhs
Total Cash from Financing Activities-47.54 Lakhs-9.85 Cr.-1.33 Cr.-2.88 Cr.
Other Liabilities1.35 Cr.-5.90 Cr.-2.12 Cr.-2.19 Cr.
Total Assets0000
Net Income-39.87 Lakhs94.54 Lakhs-56.39 Lakhs1.27 Cr.
Change in Cash1.55 Cr.8.24 Cr.-1.12 Cr.36.88 Lakhs
Effect of Exchange Rate0000
Total Cash from Operating Activities2.15 Cr.18.03 Cr.3.30 Cr.6.52 Cr.
Depreciation29.38 Lakhs28.54 Lakhs1.95 Cr.1.75 Cr.
Other Cashflows from Investing Activities0010.44 Lakhs10.44 Lakhs
Dividends Paid0000
Change to Inventory9.08 Lakhs48.06 Cr.-12.94 Cr.-12.93 Cr.
Change to Account Receivables67.87 Lakhs33.23 Cr.67.75 Lakhs-15.98 Cr.
Other Cashflows from Financing Activities-76.29 Lakhs-7.79 Cr.-3.20 Cr.-3.21 Cr.
Change to Net Income67.93 Lakhs6.45 Lakhs3.90 Cr.3.59 Cr.
Capital Expenditures-12.53 Lakhs-12.53 Lakhs-3.12 Cr.-3.13 Cr.

Financials

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax-52.99 Lakhs13.64 Lakhs71.85 Lakhs1.83 Cr.
Minority InterestNoneNoneNoneNone
Net Income28.06 Lakhs1 Cr.3.80 Cr.4.92 Cr.
Selling General Administrative95.03 Lakhs1.36 Cr.5.79 Cr.4.33 Cr.
Gross Profit3.77 Cr.4.07 Cr.41.61 Cr.31.99 Cr.
Ebit28.06 Lakhs1 Cr.3.80 Cr.4.92 Cr.
Operating Income28.06 Lakhs1 Cr.3.80 Cr.4.92 Cr.
Other Operating Expenses2.24 Cr.1.41 Cr.30.05 Cr.20.97 Cr.
Interest Expense-81.06 Lakhs-87.34 Lakhs-3.20 Cr.-2.74 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense-13.12 Lakhs-80.90 Lakhs1.28 Cr.55.79 Lakhs
Total Revenue8.42 Cr.8.21 Cr.197.43 Cr.167.76 Cr.
Total Operating Expenses8.14 Cr.7.20 Cr.193.63 Cr.162.83 Cr.
Cost of Revenue4.65 Cr.4.14 Cr.155.82 Cr.135.76 Cr.
Total Other Income Expense Net-81.05 Lakhs-87.34 Lakhs-3.08 Cr.-3.08 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.-39.87 Lakhs94.54 Lakhs-56.39 Lakhs1.27 Cr.
Net Income Applicable to Common Shares-39.87 Lakhs94.54 Lakhs-56.39 Lakhs1.27 Cr.

Balance Sheet

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Intangible Assets0000
Capital Surplus0000
Total Liabilities9.74 Cr.9.91 Cr.92.70 Cr.79.99 Cr.
Stock Holder Equity10.95 Cr.11.35 Cr.23.81 Cr.25.09 Cr.
Minority Interest0000
Other Liabilities2.40 Cr.20.34 Lakhs6.39 Cr.6.92 Cr.
Total Assets20.70 Cr.21.26 Cr.116.51 Cr.105.08 Cr.
Common Stock8.13 Cr.8.13 Cr.16.94 Cr.16.94 Cr.
Retained Earnings02.57 Cr.6.01 Cr.7.29 Cr.
Other Liabilities40.84 Lakhs58.25 Lakhs3.97 Cr.3.07 Cr.
Good Will0000
Treasury Stock2.82 Cr.64.52 Lakhs85.75 Lakhs85.75 Lakhs
Other Assets31.73 Lakhs33.43 Lakhs1.15 Cr.1.14 Cr.
Cash59.51 Lakhs17.60 Lakhs2.49 Cr.89.08 Lakhs
Current Liabilities7.61 Cr.7.88 Cr.83.82 Cr.72.17 Cr.
Long Term Asset Charges0000
Short Long Term Debt0002.68 Cr.
Other Stockholder Equity2.82 Cr.64.52 Lakhs85.75 Lakhs85.75 Lakhs
Property Plant Equipment14.63 Cr.14.80 Cr.22.88 Cr.21.82 Cr.
Total Cur. Assets5.74 Cr.6.12 Cr.92.41 Cr.82.04 Cr.
Long Term Investments01.59 Hundreds6.96 Lakhs8.40 Lakhs
Net Tangible Assets10.95 Cr.11.35 Cr.23.81 Cr.25.09 Cr.
Short Term Investments0000
Net Receivables3.23 Cr.3.91 Cr.37.32 Cr.39.95 Cr.
Long Term Debt1.72 Cr.1.44 Cr.4.90 Cr.4.73 Cr.
Inventory1.74 Cr.1.83 Cr.49.90 Cr.36.95 Cr.
Accounts Payable78.74 Lakhs1.33 Cr.60 Cr.47.59 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account